Cell Free Protein Expression Market - Cell free Expression Kits and Service Providers: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Free System, Host Organism, Expression Method, End-User and Key Geographical Regions

As per Roots Analysis, the global cell free expression market size is estimated to grow from USD 322 million in the current year to USD 627 million by 2035, at a CAGR of 6.9% during the forecast period, till 2035.

Cell Free Systems Market

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Cell Free System

Crude Cell Lysate-Based Systems
Reconstituted Systems

Type of Host Organism

Microbial Cell Free Expression Systems
Mammalian Cell Free Expression Systems
Plant-based Cell Free Expression Systems
Other Cell Free Expression Systems

Type of Expression Method

Coupled Transcription and Translation Method
Translation Method

End-user

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Other End-Users

Geographical Regions

North America
Europe
Asia-Pacific
Rest of the World

Cell Free Expression Systems Market: Growth and Trends

Over the years cell-free expression systems have become a viable alternative to the traditional cell-based protein production method. Traditional biomanufacturing is recognized as a complicated procedure that necessitates living cells and particular environments to sustain adequate homeostasis for cell proliferation. Additionally, cell-based biomanufacturing presents fundamental constraints on the efficient generation of biologics. Alternatively, cell-free protein expression systems are in vitro platforms that utilize the transcription and translation mechanisms of living cells, achieved through cell lysates, to produce different kinds of biologics, especially proteins. Several players have developed kits for the cell-free expression of enzymes, which are a category of proteins. Notably, Enzymit, a bioproduction company, employs cell-free technology to produce affordable enzymes.

In general, cell-free protein expression systems provide numerous benefits compared to the conventional method, such as the capacity to generate a wide variety of target molecules by modifying components tailored for their synthesis, increased yield, reduced development periods, and lower production costs. Protein expression without cells is conducted using cell-free systems or commercially available cell-free expression kits.

Cell-free protein expression systems have shown the ability to facilitate the synthesis of various complex proteins, such as toxic proteins, membrane proteins, and other proteins modified post-translationally, which are often difficult to produce with cell-based systems. With the increasing need for biologic products, cell-free expression has emerged as a major sector of interest for those involved in the biopharmaceutical sector.

Cell Free Protein Expression Market: Key Insights

The report delves into the current state of the cell free protein expression system market and identifies potential growth opportunities within industry. Some key findings from the report include:

Presently, more than 35 players across the globe claim to offer cell free expression services for synthesis of a variety of biomolecules.

Cell Free Protein Expression Market - IMG1

The current market landscape is fragmented, featuring the presence of both new entrants and established players catering to needs of various industries; majority of these players are based in the US.
In pursuit of building a competitive edge in this field, stakeholders are actively upgrading their existing capabilities and adding new competencies in order to enhance their respective service portfolios.
More than 90 cell free expression kits are currently available in the market for the synthesis of different types of biomolecules; these kits utilize different types of host organisms for cell free expression.
Cell free expression kits utilize a range of cell free expression systems for the synthesis of different types of biologics; majority of these include proteins, followed by oligonucleotides and others.
Owing to the rise in demand for difficult to express biomolecules, the requirement of cell free expression is increasing, prompting the stakeholders to upgrade their product offerings.
Since 2015, more than 430 patents have been filed / granted by various stakeholders in order to protect the intellectual property generated within this field.
The growing interest is evident from the rise in partnership activity; product development agreements have been the most common.

Cell Free Protein Expression Market - IMG2

Several investors having realized the opportunity within this domain, have invested more than USD 8 billion across various funding rounds in the past six years.
The cell free expression market is likely to grow at a CAGR of 6.9%, till 2035; this opportunity is expected to be well distributed across different types of cell free systems, host organisms and expression methods.

Cell Free Protein Expression Market - IMG3

Growth in this domain is anticipated to be primarily driven by the rising demand for biologics; North America is expected to capture larger share (over 50%) of the market by 2035.

Cell Free Protein Expression Market: Key Segments

Crude Cell Lysate-based Systems Capture Majority of the Current Cell Free Systems Market Share

In terms of type of cell-free system, the market is segmented across Crude Cell Lysate-Based Systems and Reconstituted Systems. Majority of the market share is captured by Crude Cell Lysate-based Systems (90%) and this trend is unlikely to change in the future. Reconstituted systems segment is likely to grow at a CAGR of 10.3% during the forecast period.

Crude Cell Lysate-based Systems is Likely to Capture Majority of the Cell Free Systems Market Share in the Future

In terms of type of expression method, the cell free systems market is segmented across coupled transcription and translation method and translation method. Over 95% of the market share is likely to be captured by crude cell lysate-based systems, growing at a CAGR of 6.6% during the forecast period.

Currently, Microbial Cell-free Expression Systems Hold the Highest Cell Free Systems Market Share

In terms of type of cell-free expression system, the cell free systems market is segmented across microbial, mammalian, plant-based and other cell-free expression systems. Around 60% of the market share is likely to be captured by microbial cell free expression systems, followed by mammalian cell free expression systems (25%) and plant-based cell free expression systems (10%).

Pharmaceutical and Biotechnology Companies are Anticipated to Hold Maximum Cell Free Systems Market Share in the Future

In terms of end-users, the cell free system market is segmented across academic and research institutes, pharmaceutical and biotechnology companies, and other end-users. Majority of the market share is likely to held by pharmaceutical and biotechnology companies (65%), growing at a CAGR of 7.9%.

North America is Likely to Propel the Cell Free Systems Market in the Future

In terms of geographical regions, the single-cell sequencing market is segmented across North America, Europe, Asia-Pacific and Rest of the World. Over 50% of the market share is captured by North America, followed by Europe (31%) and Asia-Pacific (12%).

Example Players in the Cell Free Protein Expression Market

BioLinker
Biotechrabbit
CellFreeSciences
Creative Biolabs
CUSABIO
Daicel Arbor Biosciences
LenioBio
Promega
Thermo Fisher Scientific
Touchlight

Cell Free Protein Expression Systems Market: Research Coverage

Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cell free protein systems market, focusing on key market segments, including [A] type of cell free system, [B] type of host mechanism, [C] type of expression method, [D] end-user, and [E] key geographical regions.
Market Landscape 1: A detailed assessment of cell free protein expression service providers, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] location of headquarters, [D] type of cell free service(s) offered, [E] type of associated service(s) offered, [F] type of host organism, [G] type of product(s) synthesized, [H] scale of operation and [I] type of industry served.
Market Landscape 2: A detailed assessment of the current market landscape of cell free protein expression kits, based on several relevant parameters, such as [A] type of cell free system, [B] type of host organism, [C] type of expression method, [D] type of product(s) synthesized, [E] type of template(s) used, [F] type of compatible promoter(s), [G] type of reaction format, [H] year of establishment, [I] company size (in terms of employee count), [J] location of headquarters and [K] leading players.
Company Competitiveness Analysis: A comprehensive competitive analysis of cell free expression service providers, examining factors, such as [A] supplier strength and [B] service strength.
Product Competitiveness Analysis: A product competitiveness analysis of cell free expression kits based on various relevant parameters, namely [A] developer power and [B] product competitiveness.
Company Profiles: In-depth profiles of prominent players engaged in this domain, that are currently involved in cell free systems market, focusing on [A] year of establishment, [B] location of headquarters, [C] cell free expression service portfolio, [D] recent developments and [E] an informed future outlook.
Partnerships and Collaborations An insightful analysis of the partnerships and collaborations inked between stakeholders engaged in the cell free systems market based on various relevant parameters, including [A] year of partnership, [B] type of partnership, [C] type of partner and [D] most active players.
Funding and Investment Analysis: A comprehensive examination of various funding and investments raised by developers, based on relevant parameters, including [A] such as year of funding, [B] amount invested [C] type of funding, [D] regional distribution, and [E] most active players.
Patent Analysis: An in-depth analysis of various patents that have been filed / granted for cell free systems, taking into consideration parameters, such as [A] publication year, [B] type of patent, [C] application year, [D] patent jurisdiction, [E] leading individual assignees.

Key Questions Answered in this Report

How many companies are currently engaged in this market?
Which are the leading companies in this market?
What is the current global capacity of developers?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?

Reasons to Buy this Report

The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

Additional Benefits

Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older

Product Code: RA100439

1. PREFACE

1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Chapter Overview
3.2. Introduction to Cell Free Systems
3.3. Overview of Cell Free Biomanufacturing
- 3.3.1. Advantages
- 3.3.2. Challenges
3.4. Applications of Cell Free Biomanufacturing
- 3.4.1. Applications in Healthcare Domain
- 3.4.2. Applications in Other Domains
3.5. Future Perspectives

4. MARKET LANDSCAPE: CELL FREE EXPRESSION SERVICE PROVIDERS

4.1. Chapter Overview
4.2. Cell Free Expression Service Providers: Overall Market Landscape
- 4.2.1. Analysis by Year of Establishment
- 4.2.2. Analysis by Company Size
- 4.2.3. Analysis by Location of Headquarters
- 4.2.4. Analysis by Type of Cell Free Expression Service(s) Offered
- 4.2.5. Analysis by Type of Associated Service(s) Offered
- 4.2.6. Analysis by Type of Host Organism
- 4.2.7. Analysis by Type of Product(s) Synthesized
- 4.2.8. Analysis by Scale of Operation
- 4.2.9. Analysis by Type of Industry Served

5. MARKET LANDSCAPE: CELL FREE EXPRESSION KITS

5.1. Chapter Overview
5.2. Cell Free Expression Kits: Overall Market Landscape
- 5.2.1. Analysis by Type of Cell Free System
- 5.2.2. Analysis by Type of Host Organism
- 5.2.3. Analysis by Type of Expression Method
- 5.2.4. Analysis by Type of Product(s) Synthesized
- 5.2.5. Analysis by Type of Template(s) Used
- 5.2.6. Analysis by Type of Compatible Promoter(s)
- 5.2.7. Analysis by Type of Reaction Format
- 5.2.8. Analysis by Yield of Positive Control
- 5.2.9. Analysis by Reaction Volume
- 5.2.10. Analysis by Reaction Temperature
- 5.2.11. Analysis by Incubation Time
- 5.2.12. Analysis by Number of Reactions per Kit
- 5.2.13. Analysis by Kit Price
5.3. Cell Free Expression Kit Providers Landscape
- 5.3.1. Analysis by Year of Establishment
- 5.3.2. Analysis by Company Size
- 5.3.3. Analysis by Location of Headquarters
- 5.3.4. Most Active Players: Analysis by Number of Cell free Expression Kits Developed

6. CELL FREE EXPRESSION SERVICE PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS

6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Company Competitiveness Analysis: Cell Free Expression Service Providers
- 6.4.1. Company Competitiveness Analysis: Small Service Providers
- 6.4.2. Company Competitiveness Analysis: Mid-sized Service Providers
- 6.4.3. Company Competitiveness Analysis: Large and Very Service Providers

7. CELL FREE EXPRESSION KITS: PRODUCT COMPETITIVENESS ANALYSIS

7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Cell Free Expression Kits
- 7.4.1. Product Competitiveness Analysis: Cell Free Expression Kits Developed by Players based in North America
- 7.4.2. Product Competitiveness Analysis: Cell Free Expression Kits Developed by Players based in Europe
- 7.4.3. Product Competitiveness Analysis: Cell Free Expression Kits Developed by Players based in Asia-Pacific and Rest of the World

8. COMPANY PROFILES: CELL FREE EXPRESSION SERVICE PROVIDERS

8.1. Chapter Overview
8.2. BioLinker
- 8.2.1. Company Overview
- 8.2.2. Cell Free Expression Service Portfolio
- 8.2.3. Recent Developments and Future Outlook
8.3. CUSABIO
- 8.3.1. Company Overview
- 8.3.2. Cell Free Expression Service Portfolio
- 8.3.3. Recent Developments and Future Outlook
8.4. LenioBio
- 8.4.1. Company Overview
- 8.4.2. Cell Free Expression Service Portfolio
- 8.4.3. Recent Developments and Future Outlook
8.5. Touchlight
- 8.5.1. Company Overview
- 8.5.2. Cell Free Expression Service Portfolio
- 8.5.3. Recent Developments and Future Outlook

9. COMPANY PROFILES: CELL FREE EXPRESSION KIT PROVIDERS

9.1. Chapter Overview
9.2. biotechrabbit
- 9.2.1. Company Overview
- 9.2.2. Cell Free Expression Kit Portfolio
- 9.2.3 Recent Developments and Future Outlook
9.3. CellFree Sciences
- 9.3.1. Company Overview
- 9.3.2. Cell Free Expression Kit Portfolio
- 9.3.3 Recent Developments and Future Outlook
9.4. Creative Biolabs
- 9.4.1. Company Overview
- 9.4.2. Cell Free Expression Kit Portfolio
- 9.4.3 Recent Developments and Future Outlook
9.5. Diacel Arbor Biosciences
- 9.5.1. Company Overview
- 9.5.2. Cell Free Expression Kit Portfolio
- 9.5.3 Recent Developments and Future Outlook
9.6. Promega
- 9.6.1. Company Overview
- 9.6.2. Cell Free Expression Kit Portfolio
- 9.6.3 Recent Developments and Future Outlook
9.7. Thermo Fisher Scientific
- 9.7.1. Company Overview
- 9.7.2. Cell Free Expression Kit Portfolio
- 9.7.3. Recent Developments and Future Outlook

10. PARTNERSHIPS AND COLLABORATIONS

10.1. Chapter Overview
10.2. Partnership Models
10.3. Cell free System: Partnerships and Collaborations
- 10.3.1 Analysis by Year of Partnership
- 10.3.2. Analysis by Type of Partnership
- 10.3.3. Analysis by Year and Type of Partnership
- 10.3.4. Analysis by Focus Area
- 10.3.5. Analysis by Type of Partner
- 10.3.6. Most Active Players: Analysis by Number of Partnerships
- 10.3.7. Local and International Agreements
- 10.3.8. Intercontinental and Intracontinental Agreements

11. FUNDING AND INVESTMENT ANALYSIS

11.1. Chapter Overview
11.2. Types of Funding
11.3. Cell free System: Funding and Investment Analysis
- 11.3.1. Analysis of Instances by Year of Investment
- 11.3.2. Analysis of Amount Invested by Year of Investment
- 11.3.3. Analysis of Instances by Type of Funding
- 11.3.4. Analysis of Amount Invested by Type of Funding
- 11.3.5. Analysis by Instances of Type of Investor
- 11.3.6. Most Active Players: Analysis by Number of Instances
- 11.3.7. Most Active Players: Analysis by Amount Invested
- 11.3.8. Analysis of Amount Invested by Geography
  - 11.3.8.1. Analysis by Region
  - 11.3.8.2. Analysis by Country

12. PATENT ANALYSIS

12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Cell free System: Patent Analysis
- 12.3.1. Analysis by Patent Publication Year
- 12.3.2. Analysis by Patent Application Year
- 12.3.3. Analysis by Annual Number of Granted Patents and Patent Applications
- 12.3.4. Analysis by Patent Jurisdiction
- 12.3.5. Analysis by CPC Symbols
- 12.3.6. Analysis by Type of Applicant
- 12.3.7. Leading Industry Players: Analysis by Number of Patents
- 12.3.8. Leading Non-Industry Players: Analysis by Number of Patents
- 12.3.9. Leading Individual Assignees: Analysis by Number of Patents
12.4. Cell free System: Patent Benchmarking Analysis
- 12.4.1. Analysis by Patent Characteristics
12.5. Cell free System: Patent Valuation
12.6. Leading Patents: Analysis by Number of Citations

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

13.1. Chapter Overview
13.2. Key Assumptions and Forecast Methodology
13.3. Global Cell Free Expression Market, Till 2035
- 13.3.1. Cell Free Expression Market: Distribution by Type of Cell Free System
  - 13.3.1.1. Cell Free Expression Market for Crude Cell Lysate-based Systems, Till 2035
  - 13.3.1.2. Cell Free Expression Market for Reconstituted Systems, Till 2035
- 13.3.2. Cell Free Expression Market: Distribution by Type of Host Organism
  - 13.3.2.1. Cell Free Expression Market for Microbial Cell Free Expression Systems, Till 2035
  - 13.3.2.2. Cell Free Expression Market for Mammalian Cell Free Expression Systems, Till 2035
  - 13.3.2.3. Cell Free Expression Market for Plant-based Cell Free Expression Systems, Till 2035
  - 13.3.2.4. Cell Free Expression Market for Other Cell Free Expression Systems, Till 2035
- 13.3.3. Cell Free Expression Market: Distribution by Type of Expression Method
  - 13.3.3.1. Cell Free Expression Market for Coupled Transcription and Translation Method, Till 2035
  - 13.3.3.2. Cell Free Expression Market for Translation Method, Till 2035
- 13.3.4. Cell Free Expression Market: Distribution by End-User
  - 13.3.4.1. Cell Free Expression Market for Pharmaceutical and Biotechnology Companies, Till 2035
  - 13.3.4.2. Cell Free Expression Market for Academic and Research Institutes, Till 2035
  - 13.3.4.3. Cell Free Expression Market for Other End-Users, Till 2035
- 13.3.5. Cell Free Expression Market: Distribution by Key Geographical Regions
  - 13.3.5.1. Cell Free Expression Market in North America, Till 2035
  - 13.3.5.2. Cell Free Expression Market in Europe, Till 2035
  - 13.3.5.3. Cell Free Expression Market in Asia-Pacific, Till 2035
  - 13.3.5.4. Cell Free Expression Market in Rest of the World, Till 2035

14. EXECUTIVE INSIGHTS

14.1. Chapter Overview
14.2. Company A
- 14.2.1. Company Snapshot
- 14.2.2. Interview Transcript
14.3. Company B
- 14.3.1. Company Snapshot
- 14.3.2. Interview Transcript

15. CONCLUDING REMARKS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

Product Code: RA100439

List of Tables

Table 4.1 Cell free Expression Service Providers: Information on Year of Establishment, Company Size, Location of Headquarters, Type of Host Organism, Type of Cell free Expression Service(s) Offered, and Type of Associated Service(s) Offered
Table 4.2 Cell free Expression Service Providers: Information on Type of Product(s) Synthesized, Scale of Operation and Type of Industry Served
Table 5.1 Cell free Expression Kits: Information on Type of Cell free System, Type of Host Organism, Type of Expression Method, and Type of Product(s) Synthesized
Table 5.2 Cell free Expression Kits: Information on Type of Template(s) Used, Type of Compatible Promoter(s), Type of Reaction Format, Yield of Positive Control, Reaction Volume, Reaction Temperature, Incubation Time, Number of Reactions per Kit and Kit Price
Table 5.3 Cell free Expression Kit Providers: Information on Year of Establishment, Location of Headquarters, Company Size and Type of Organization
Table 8.1 Leading Cell free Expression Service Providers
Table 8.2 BioLinker: Company Overview
Table 8.3 BioLinker: Cell free Expression Service Portfolio
Table 8.4 CUSABIO: Company Overview
Table 8.5 CUSABIO: Cell free Expression Service Portfolio
Table 8.6 LenioBio: Company Overview
Table 8.7 LenioBio: Cell free Expression Service Portfolio
Table 8.8 LenioBio: Recent Developments and Future Outlook
Table 8.9 Touchlight: Company Overview
Table 8.10 Touchlight: Cell free Expression Service Portfolio
Table 8.11 Touchlight: Recent Developments and Future Outlook
Table 9.1 Leading Cell free Expression Kit Providers
Table 9.2 biotechrabbit: Company Overview
Table 9.3 biotechrabbit: Cell free Expression Kit Portfolio
Table 9.4 CellFree Sciences: Company Overview
Table 9.5 CellFree Sciences: Cell free Expression Kit Portfolio
Table 9.6 Creative Biolabs: Company Overview
Table 9.7 Creative Biolabs: Cell free Expression Kit Portfolio
Table 9.8 Daicel Arbor Biosciences: Company Overview
Table 9.9 Daicel Arbor Biosciences: Cell free Expression Kit Portfolio
Table 9.10 Promega: Company Overview
Table 9.11 Promega: Cell free Expression Kit Portfolio
Table 9.12 Thermo Fisher Scientific: Company Overview
Table 9.13 Thermo Fisher Scientific: Cell free Expression Kit Portfolio
Table 9.14 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 10.1 Cell free System: List of Partnerships and Collaborations, 2018-2023
Table 11.1 Cell free System: List of Funding and Investments, 2018-2023
Table 12.1 Patent Analysis: Top CPC Symbols
Table 12.2 Patent Analysis: Top CPC Codes
Table 12.3 Patent Analysis: Summary of Benchmarking Analysis
Table 12.4 Patent Analysis: Categorization based on Weighted Valuation Scores
Table 12.5 Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 12.6 Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 14.1 Gene Frontier: Company Snapshot
Table 14.2 LenioBio: Company Snapshot
Table 14.3 Synthelis: Company Snapshot
Table 16.1 Cell free Expression Service Providers: Distribution by Year of Establishment
Table 16.2 Cell free Expression Service Providers: Distribution by Company Size
Table 16.3 Cell free Expression Service Providers: Distribution by Location of Headquarters
Table 16.4 Cell free Expression Service Providers: Distribution by Type of Cell free Expression Service(s) Offered
Table 16.5 Cell free Expression Service Providers: Distribution by Type of Associated Service(s) Offered
Table 16.6 Cell free Expression Service Providers: Distribution by Type of Host Organism
Table 16.7 Cell free Expression Service Providers: Distribution by Type of Product(s) Synthesized
Table 16.8 Cell free Expression Service Providers: Distribution by Scale of Operation
Table 16.9 Cell free Expression Service Providers: Distribution by Type of Industry Served
Table 16.10 Cell free Expression Kits: Distribution by Type of Cell free System
Table 16.11 Cell free Expression Kits: Distribution by Type of Host Organism
Table 16.12 Cell free Expression Kits: Distribution by Type of Expression Method
Table 16.13 Cell free Expression Kits: Distribution by Type of Product(s) Synthesized
Table 16.14 Cell free Expression Kits: Distribution by Type of Template(s) Used
Table 16.15 Cell free Expression Kits: Distribution by Type of Compatible Promoter(s)
Table 16.16 Cell free Expression Kits: Distribution by Type of Reaction Format
Table 16.17 Cell free Expression Kits: Distribution by Yield of Positive Control
Table 16.18 Cell free Expression Kits: Distribution by Reaction Volume
Table 16.19 Cell free Expression Kits: Distribution by Reaction Temperature
Table 16.20 Cell free Expression Kits: Distribution by Incubation Time
Table 16.21 Cell free Expression Kits: Distribution by Number of Reactions per Kit
Table 16.22 Cell free Expression Kits: Distribution by Kit Price
Table 16.23 Cell free Expression Kit Providers: Distribution by Year of Establishment
Table 16.24 Cell free Expression Kit Providers: Distribution by Company Size
Table 16.25 Cell free Expression Kit Providers: Distribution by Location of Headquarters
Table 16.26 Most Active Players: Distribution by Number of Cell free Expression Kits Developed
Table 16.27 Partnerships and Collaborations: Cumulative Year-wise Trend
Table 16.28 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.29 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 16.30 Partnerships and Collaborations: Distribution by Focus Area
Table 16.31 Partnerships and Collaborations: Distribution by Type of Partner
Table 16.32 Most Active Players: Distribution by Number of Partnerships
Table 16.33 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 16.34 Partnerships and Collaborations: Local and International Agreements
Table 16.35 Funding and Investment Analysis: Cumulative Distribution of Number of Instances by Year, 2018-2023
Table 16.36 Funding and Investment Analysis: Cumulative Distribution of Amount Invested by Year, 2018-2023 (USD Million)
Table 16.37 Funding and Investment Analysis: Distribution of Instances by Type of Funding
Table 16.38 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Table 16.39 Funding and Investment Analysis: Distribution of Instances by Type of Investor
Table 16.40 Most Active Players: Distribution by Number of Instances
Table 16.41 Most Active Players: Distribution by Amount Invested (USD Million)
Table 16.42 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Table 16.43 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Table 16.44 Patent Analysis: Distribution by Type of Patent
Table 16.45 Patent Analysis: Distribution by Patent Publication Year
Table 16.46 Patent Analysis: Distribution by Patent Application Year
Table 16.47 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year
Table 16.48 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
Table 16.49 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
Table 16.50 Patent Analysis: Distribution by CPC Symbols
Table 16.51 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Table 16.52 Leading Industry Players: Distribution by Number of Patents
Table 16.53 Leading Non-Industry Players: Distribution by Number of Patents
Table 16.54 Leading Individual Assignees: Distribution by Number of Patents
Table 16.55 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Table 16.56 Patent Analysis: Distribution by Patent Age
Table 16.57 Cell free System: Patent Valuation
Table 16.58 Global Cell free Expression Market: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.59 Cell free Expression Market: Distribution by Type of Cell free System
Table 16.60 Cell free Expression Market for Crude Cell Lysate-based Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.61 Cell free Expression Market for Reconstituted Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.62 Cell free Expression Market: Distribution by Type of Host Organism
Table 16.63 Cell free Expression Market for Microbial Cell free Expression Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.64 Cell free Expression Market for Mammalian Cell free Expression Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.65 Cell free Expression Market for Plant-based Cell free Expression Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.66 Cell free Expression Market for Other Cell free Expression Systems: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.67 Cell free Expression Market: Distribution by Type of Expression Method
Table 16.68 Cell free Expression Market for Coupled Transcription and Translation Method: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.69 Cell free Expression Market for Translation Method: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.70 Cell free Expression Market: Distribution by End-User
Table 16.71 Cell free Expression Market for Pharmaceutical and Biotechnology Companies: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.72 Cell free Expression Market for Academic and Research Institutes: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.73 Cell free Expression Market for Other End-Users: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.74 Cell free Expression Market: Distribution by Key Geographical Regions
Table 16.75 Cell free Expression Market in North America: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.76 Cell free Expression Market in Europe: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.77 Cell free Expression Market in Asia-Pacific: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)
Table 16.78 Cell free Expression Market in Rest of the World: Conservative, Base and Optimistic Scenarios, Till 2035 (USD Million)

List of Figures

Figure 2.1 Executive Summary: Overall Market Landscape of Cell free Expression Service Providers
Figure 2.2 Executive Summary: Overall Market Landscape of Cell free Expression Kits
Figure 2.3 Executive Summary: Partnerships and Collaborations
Figure 2.4 Executive Summary: Funding and Investment Analysis
Figure 2.5 Executive Summary: Patent Analysis
Figure 2.6 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Components of Cell free Reaction
Figure 3.2 Applications of Cell free Biomanufacturing
Figure 4.1 Cell free Expression Service Providers: Distribution by Year of Establishment
Figure 4.2 Cell free Expression Service Providers: Distribution by Company Size
Figure 4.3 Cell free Expression Service Providers: Distribution by Location of Headquarters
Figure 4.4 Cell free Expression Service Providers: Distribution by Type of Cell free Biomanufacturing Service(s) Offered
Figure 4.5 Cell free Expression Service Providers: Distribution by Type of Associated Service(s) Offered
Figure 4.6 Cell free Expression Service Providers: Distribution by Type of Host Organism
Figure 4.7 Cell free Expression Service Providers: Distribution by Type of Product(s) Synthesized
Figure 4.8 Cell free Expression Service Providers: Distribution by Scale of Operation
Figure 4.9 Cell free Expression Service Providers: Distribution by Type of Industry Served
Figure 5.1 Cell free Expression Kits: Distribution by Type of Cell free System
Figure 5.2 Cell free Expression Kits: Distribution by Type of Host Organism
Figure 5.3 Cell free Expression Kits: Distribution by Type of Expression Method
Figure 5.4 Cell free Expression Kits: Distribution by Type of Product(s) Synthesized
Figure 5.5 Cell free Expression Kits: Distribution by Type of Template(s) Used
Figure 5.6 Cell free Expression Kits: Distribution by Type of Compatible Promoter(s)
Figure 5.7 Cell free Expression Kits: Distribution by Type of Reaction Format
Figure 5.8 Cell free Expression Kits: Distribution by Yield of Positive Control
Figure 5.9 Cell free Expression Kits: Distribution by Reaction Volume
Figure 5.10 Cell free Expression Kits: Distribution by Reaction Temperature
Figure 5.11 Cell free Expression Kits: Distribution by Incubation Time
Figure 5.12 Cell free Expression Kits: Distribution by Number of Reactions per Kit
Figure 5.13 Cell free Expression Kits: Distribution by Kit Price
Figure 5.14 Cell free Expression Kit Providers: Distribution by Year of Establishment
Figure 5.15 Cell free Expression Kit Providers: Distribution by Company Size
Figure 5.16 Cell free Expression Kit Providers: Distribution by Location of Headquarters
Figure 5.17 Most Active Players: Distribution by Number of Cell free Expression Kits Developed
Figure 6.1 Company Competitiveness Analysis: Small Service Providers
Figure 6.2 Company Competitiveness Analysis: Leading Small Service Providers
Figure 6.3 Company Competitiveness Analysis: Mid-sized Service Providers
Figure 6.4 Company Competitiveness Analysis: Large and Very Large Service Providers
Figure 7.1 Product Competitiveness Analysis: Cell free Expression Kits Developed by Players based in North America
Figure 7.2 Product Competitiveness Analysis: Popular Cell free Expression Kits Developed by Players based in North America
Figure 7.3 Product Competitiveness Analysis: Cell free Expression Kits Developed by Players based in Europe
Figure 7.4 Product Competitiveness Analysis: Popular Cell free Expression Kits Developed by Players based in Europe
Figure 7.5 Product Competitiveness Analysis: Cell free Expression Kits Developed by Players based in Asia Pacific and Rest of the World
Figure 7.6 Product Competitiveness Analysis: Popular Cell free Expression Kits Developed by Players based in Asia Pacific and Rest of the World
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Trend
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 10.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 10.5 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.6 Most Active Players: Distribution by Number of Partnerships
Figure 10.7 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.8 Partnerships and Collaborations: Local and International Agreements
Figure 11.1 Funding and Investment Analysis: Cumulative Distribution of Number of Instances by Year, 2018-2023
Figure 11.2 Funding and Investment Analysis: Cumulative Distribution of Amount Invested by Year, 2018-2023 (USD Million)
Figure 11.3 Funding and Investment Analysis: Distribution of Instances by Type of Funding
Figure 11.4 Funding and Investment Analysis: Distribution of Amount Invested by Type of Funding (USD Million)
Figure 11.5 Funding and Investment Analysis: Distribution of Instances by Type of Investor
Figure 11.6 Most Active Players: Distribution by Number of Instances
Figure 11.7 Most Active Players: Distribution by Amount Invested (USD Million)
Figure 11.8 Funding and Investment Analysis: Distribution of Amount Invested by Region (USD Million)
Figure 11.9 Funding and Investment Analysis: Distribution of Amount Invested by Country (USD Million)
Figure 12.1 Patent Analysis: Distribution by Type of Patent
Figure 12.2 Patent Analysis: Distribution by Patent Publication Year
Figure 12.3 Patent Analysis: Distribution by Patent Application Year
Figure 12.4 Patent Analysis: Distribution of Granted Patents and Patent Applications by Publication Year
Figure 12.5 Patent Analysis: Distribution by Patent Jurisdiction (Region-wise)
Figure 12.6 Patent Analysis: Distribution by Patent Jurisdiction (Country-wise)
Figure 12.7 Patent Analysis: Distribution by CPC Symbols
Figure 12.8 Patent Analysis: Cumulative Year-wise Distribution by Type of Applicant
Figure 12.9 Leading Industry Players: Distribution by Number of Patents
Figure 12.1 Leading Non-Industry Players: Distribution by Number of Patents
Figure 12.11 Leading Individual Assignees: Distribution by Number of Patents
Figure 12.12 Patent Benchmarking Analysis: Distribution of Leading Industry Players by Patent Characteristics (CPC Codes)
Figure 12.13 Patent Analysis: Distribution by Patent Age
Figure 12.14 Cell free System: Patent Valuation
Figure 13.1 Global Cell free Expression Market, Till 2035 (USD Million)
Figure 13.2 Cell free Expression Market: Distribution by Type of Cell free System
Figure 13.3 Cell free Expression Market for Crude Cell Lysate-based Systems, Till 2035 (USD Million)
Figure 13.4 Cell free Expression Market for Reconstituted Systems, Till 2035 (USD Million)
Figure 13.5 Cell free Expression Market: Distribution by Type of Host Organism
Figure 13.6 Cell free Expression Market for Microbial Cell free Expression Systems, Till 2035 (USD Million)
Figure 13.7 Cell free Expression Market for Mammalian Cell free Expression Systems, Till 2035 (USD Million)
Figure 13.8 Cell free Expression Market for Plant-based Cell free Expression Systems, Till 2035 (USD Million)
Figure 13.9 Cell free Expression Market for Other Cell free Expression Systems, Till 2035 (USD Million)
Figure 13.10 Cell free Expression Market: Distribution by Type of Expression Method
Figure 13.11 Cell free Expression Market for Coupled Transcription and Translation Method, Till 2035 (USD Million)
Figure 13.12 Cell free Expression Market for Translation Method, Till 2035 (USD Million)
Figure 13.13 Cell free Expression Market: Distribution by End-User
Figure 13.14 Cell free Expression Market for Pharmaceutical and Biotechnology Companies, Till 2035 (USD Million)
Figure 13.15 Cell free Expression Market for Academic and Research Institutes, Till 2035 (USD Million)
Figure 13.16 Cell free Expression Market for Other End-Users, Till 2035 (USD Million)
Figure 13.17 Cell free Expression Market: Distribution by Key Geographical Regions
Figure 13.18 Cell free Expression Market in North America, Till 2035 (USD Million)
Figure 13.19 Cell free Expression Market in Europe, Till 2035 (USD Million)
Figure 13.20 Cell free Expression Market in Asia-Pacific, Till 2035 (USD Million)
Figure 13.21 Cell free Expression Market in Rest of the World, Till 2035 (USD Million)
Figure 15.1 Concluding Remarks: Cell free Expression Service Providers Market Landscape
Figure 15.2 Concluding Remarks: Cell free Expression Kits Market Landscape
Figure 15.3 Concluding Remarks: Partnerships and Collaborations
Figure 15.4 Concluding Remarks: Funding and Investment Analysis
Figure 15.5 Concluding Remarks: Patent Analysis
Figure 15.6 Concluding Remarks: Market Forecast and Opportunity Analysis

Cell Free Protein Expression Market - Cell free Expression Kits and Service Providers: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Free System, Host Organism, Expression Method, End-User and Key Geographical Regions

Description

Table of Contents

List of Tables

Example Players in the Cell Free Protein Expression Market

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. INTRODUCTION

4. MARKET LANDSCAPE: CELL FREE EXPRESSION SERVICE PROVIDERS

5. MARKET LANDSCAPE: CELL FREE EXPRESSION KITS

6. CELL FREE EXPRESSION SERVICE PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS

7. CELL FREE EXPRESSION KITS: PRODUCT COMPETITIVENESS ANALYSIS

8. COMPANY PROFILES: CELL FREE EXPRESSION SERVICE PROVIDERS

9. COMPANY PROFILES: CELL FREE EXPRESSION KIT PROVIDERS

10. PARTNERSHIPS AND COLLABORATIONS

11. FUNDING AND INVESTMENT ANALYSIS

12. PATENT ANALYSIS

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

14. EXECUTIVE INSIGHTS

15. CONCLUDING REMARKS

16. APPENDIX 1: TABULATED DATA

17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Tables

List of Figures